适体市场:按类型（核酸、□适体）、应用、最终用户、地区 - 规模、份额、前景、机会分析，2022-2030 年

适配体是短的单链 DNA 或 RNA（ssDNA 或 ssRNA）分子，可以高度特异性地结合特定的靶蛋白、脂质和核酸分子。适体也可以与药物偶联并充当药物递送系统。例如，通过将适体与化学治疗剂结合，可以仅靶向并结合癌细胞，而不影响健康组织。此外，引发不需要的免疫反应的可能性低、热稳定性高和成本效益高，预计会增加对适体的需求。适体是通过一种称为指数富集配体系统进化 (SELEX) 的技术製造的，该技术需要时间和迭代步骤。为了克服这一缺点，医疗设备製造商 Vivonics Inc. 开发了一种称为 RIDA（Rapid Isolation of DNA Aptamers）的一步高速技术并获得了专利，用于分离具有高亲和力和高选择性的适体。预计这些因素将推动适体的采用。

市场动态

预计主要市场参与者的许可协议等无机策略的增加将在预测期内推动全球适体市场。例如，2022 年 9 月，生物技术公司 CAGE Bio Inc. 和研究型公司 TAGCyx Biotechnologies Inc. 宣布，他们已签订许可协议，开发一种免疫皮肤病药物 TAGX-0003。根据该协议，CAGE Bio Inc.将获得开发药物（TAGX-0003）的许可，TAGCyx Biotechnologies Inc.将获得预付款、销售里程碑和与销售相关的特许权使用费。 TAGX-0003是一种具有强干扰素Gamma拮抗活性的DNA适配体，有望成为一种无创、有效、安全的皮肤病穿透性治疗药物。

这项研究的主要特点

• 本报告对全球适体市场进行了深入分析，提供了以 2021 年为基准年的预测期 (2022-2030) 的市场规模和復合年增长率 (CAGR%)。
• 它揭示了不同细分市场的潜在收入机会，并为该市场概述了一个有吸引力的投资建议矩阵。
• 它还提供重要的见解，例如市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争战略。
• 根据公司亮点、产品组合、主要亮点、绩效和战略等参数介绍全球适体市场领先企业的概况。
• 本研究涵盖的主要公司包括 Ophthotech Corporation、Aptamer Sciences, Inc.、Novartis AG、NeoNeuro SAS、Aptagen LLC、Aptus Biotech S.L.、AM Biotechnologies, LLC、Base Pair Biotechnologies、Vivoonics Inc.、CAGE Bio Inc ., TAGCyx Biotechnologies Inc., AstraZeneca, GlyTech, Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies, Inc., SomaLogic Operating Co., Inc., Amsbio, and IVERIC bio, Inc.,
• 这份报告中的见解将使企业营销人员和高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• Aptamers 全球市场报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球适体市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第二章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 市场概况:按类型分类
  • 市场概况:按应用分类
  • 市场概况:按最终用户分类
  • 市场概况:按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 司机
  • 约束因素
  • 市场机会
• 影响分析
• 市场趋势
• 近期趋势
• 收购和合作场景
• 技术概览
• 监管情景
• 价格分析
• 害虫分析

第 4 章全球适体市场:冠状病毒 (COVID-19) 大流行的影响

• 总体影响
• 政府举措
• COVID-19 对市场的影响

第 5 章全球适体市场:按类型，2017-2030

• 核酸系统
• 基于 DNA 的适体
• 基于 RNA 的适体
• XNA适体
• □适体

第 6 章全球适体市场:按应用，2017-2030

• 诊断
• 治疗药物
• 研发领域

第 7 章全球适体市场:按最终用户分类，2017-2030

• 生物技术公司、製药公司
• 学术和研究机构
• 委託研究机构

第 8 章全球适体市场:按地区划分，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲地区
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第9章竞争格局

• Ophthotech Corporation
• Aptamer Sciences, Inc.
• Novartis AG
• NeoNeuro SAS
• Aptagen, LLC
• Aptus Biotech S.L.
• AM Biotechnologies, LLC
• Base Pair Biotechnologies
• Vivonics Inc.
• CAGE Bio Inc.
• TAGCyx Biotechnologies Inc.
• AstraZeneca
• GlyTech, Inc.
• GC Biopharma Corp.
• Achiko AG
• Agilent Technologies, Inc.
• SomaLogic Operating Co., Inc.
• Amsbio
• IVERIC bio, Inc.,

第 10 章

• 调查方法
• 关于出版商

Aptamers are short single-stranded DNA or RNA (ssDNA or ssRNA) molecules that bind to a specific target protein, lipid, or nucleic acid molecules with high specificity. Aptamers can also be conjugated to drugs, and work as drug-delivery systems. For example, aptamers have been conjugated with chemotherapy drugs to turn target and bind to only cancerous cells and leave healthy tissue untouched. Furthermore, factors such as lesser possibility of provoking undesired immune responses, high thermal stability, and cost-efficiency provide are expected to boost demand for aptamers. These are produced through a technique called Systematic Evolution of Ligands by Exponential enrichment (SELEX), which is time-consuming and involves iterative steps. Thus, to overcome this disadvantage, Vivonics Inc., a medical device company, developed and patented a one-step rapid technique named Rapid Isolation of DNA Aptamers (RIDA) for the isolation of high affinity and high selectivity aptamers. Such factors are expected to fuel the adoption of aptamers.

Market Dynamics

Increasing number of inorganic strategies such as license agreement by the key market players is expected to drive the global aptamers market over the forecast period. For instance, in September 2022, CAGE Bio Inc., a biotechnology company and TAGCyx Biotechnologies Inc., a research based company, announced that they had executed a license agreement for the development of TAGX-0003 for the treatment of Immuno dermatology diseases. Under this agreement, CAGE Bio Inc. will receive a license to develop the drug (TAGX-0003) and TAGCyx Biotechnologies Inc., will receive an upfront payment, sales milestone payments and sales related royalties. TAGX-0003 is a DNA aptamer that possess potent interferon gamma antagonistic activity which penetrates into the skin enabling a non-invasive, efficacious and safe treatment for dermatological diseases.

Key features of the study:

• This report provides an in-depth analysis of the global aptamers market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global aptamers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, NeoNeuro SAS, Aptagen LLC, Aptus Biotech S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies, Vivonics Inc., CAGE Bio Inc., TAGCyx Biotechnologies Inc., AstraZeneca, GlyTech, Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies, Inc., SomaLogic Operating Co., Inc., Amsbio, and IVERIC bio, Inc.,
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global aptamers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aptamers market

Detailed Segmentation:

• Global Aptamers Market, By Type:
  • Nucleic Acid Aptamers
    • DNA-based Aptamers
    • RNA-based Aptamers
    • XNA-based Aptamers
  • Peptide Aptamers
• Global Aptamers Market, By Application:
  • Diagnostics
  • Therapeutics
  • Research and Development
• Global Aptamers Market, By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutions
  • Contract Research Organization
• Global Aptamers Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Ophthotech Corporation*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Aptamer Sciences, Inc.
  • Novartis AG
  • NeoNeuro SAS
  • Aptagen, LLC
  • Aptus Biotech S.L.
  • AM Biotechnologies, LLC
  • Base Pair Biotechnologies
  • Vivonics Inc.
  • CAGE Bio Inc.
  • TAGCyx Biotechnologies Inc.
  • AstraZeneca
  • GlyTech, Inc.
  • GC Biopharma Corp.
  • Achiko AG
  • Agilent Technologies, Inc.
  • SomaLogic Operating Co., Inc.
  • Amsbio
  • IVERIC bio, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• Pricing Analysis
• PEST Analysis

4. Global Aptamers Market - Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Aptamers Market, By Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Nucleic Acid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• DNA-based Aptamers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• RNA-based Aptamers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• XNA-based Aptamers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Peptide Aptamers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Aptamers Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Therapeutics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Research and Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Aptamers Market, By End User, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Biotechnology and Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Academic and Research Institutions
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Contract Research Organization
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Aptamers Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Ophthotech Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Aptamer Sciences, Inc.
• Novartis AG
• NeoNeuro SAS
• Aptagen, LLC
• Aptus Biotech S.L.
• AM Biotechnologies, LLC
• Base Pair Biotechnologies
• Vivonics Inc.
• CAGE Bio Inc.
• TAGCyx Biotechnologies Inc.
• AstraZeneca
• GlyTech, Inc.
• GC Biopharma Corp.
• Achiko AG
• Agilent Technologies, Inc.
• SomaLogic Operating Co., Inc.
• Amsbio
• IVERIC bio, Inc.,

10. Section

• Research Methodology
• About Us